Advertisement

Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px
Organisation › Details

Santhera Pharmaceuticals (USA) Inc.

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative pharmaceutical products for the treatment of severe neuromuscular and neurodegenerative diseases, an area of high unmet medical need which includes many orphan and niche indications with no current therapy. Santhera's first product, Catena® to treat Friedreich's Ataxia is marketed in Canada. *

 

Period Start 2011-04-28 existent
  Group Santhera (Group)
Product Industry pharmaceutical
     
Region Region Burlington, MA
  Country United States (USA)
  City Burlington, MA
    Address record changed: 2021-11-05
     
Basic data Employees n. a.
     
    * Document for �About Section�: 
     
   
Record changed: 2021-11-05

Advertisement

Picture [iito] Fighting Customers 650x100px

More documents for Santhera (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px




» top